HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Defective carbohydrate metabolism in mice homozygous for the tubby mutation.

Abstract
Tub is a member of a small gene family, the tubby-like proteins (TULPs), with predominant expression in neurons. Mice carrying a mutation in Tub develop retinal and cochlear degeneration as well as late-onset obesity with insulin resistance. During behavioral and metabolic testing, we found that homozygous C57BL/6J-Tub(tub) mice have a lower respiratory quotient than C57BL/6J controls before the onset of obesity, indicating that tubby homozygotes fail to activate carbohydrate metabolism and instead rely on fat metabolism for energy needs. In concordance with this, tubby mice show higher excretion of ketone bodies and accumulation of glycogen in the liver. Quantitation of liver mRNA levels shows that, during the transition from light to dark period, tubby mice fail to induce glucose-6-phosphate dehydrogenase (G6pdh), the rate-limiting enzyme in the pentose phosphate pathway that normally supplies NADPH for de novo fatty acid synthesis and glutathione reduction. Reduced G6PDH protein levels and enzymatic activity in tubby mice lead accordingly to lower levels of NADPH and reduced glutathione (GSH), respectively. mRNA levels for the lipolytic enzymes acetyl-CoA synthetase and carnitine palmitoyltransferase are increased during the dark cycle and decreased during the light period, and several citric acid cycle genes are dysregulated in tubby mice. Examination of hypothalamic gene expression showed high levels of preproorexin mRNA leading to accumulation of orexin peptide in the lateral hypothalamus. We hypothesize that abnormal hypothalamic orexin expression leads to changes in liver carbohydrate metabolism and may contribute to the moderate obesity observed in tubby mice.
AuthorsYun Wang, Kevin Seburn, Lawrence Bechtel, Bruce Y Lee, Jin P Szatkiewicz, Patsy M Nishina, Jürgen K Naggert
JournalPhysiological genomics (Physiol Genomics) Vol. 27 Issue 2 Pg. 131-40 (Oct 11 2006) ISSN: 1531-2267 [Electronic] United States
PMID16849632 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Agouti-Related Protein
  • Intercellular Signaling Peptides and Proteins
  • Intracellular Signaling Peptides and Proteins
  • Liver Glycogen
  • Neuropeptide Y
  • Neuropeptides
  • Orexins
  • Proteins
  • Tub protein, mouse
  • Carbon Dioxide
  • NADP
  • Glucosephosphate Dehydrogenase
  • Carnitine O-Palmitoyltransferase
  • Acetate-CoA Ligase
  • Glutathione
  • Oxygen
Topics
  • Acetate-CoA Ligase (biosynthesis, genetics)
  • Adaptor Proteins, Signal Transducing
  • Agouti-Related Protein
  • Animals
  • Brain Chemistry
  • Carbohydrate Metabolism (genetics)
  • Carbon Dioxide (metabolism)
  • Carnitine O-Palmitoyltransferase (biosynthesis, genetics)
  • Circadian Rhythm
  • Citric Acid Cycle (genetics)
  • Cochlear Diseases (genetics)
  • Eating
  • Energy Metabolism (genetics)
  • Enzyme Induction (genetics)
  • Genes, Recessive
  • Glucosephosphate Dehydrogenase (biosynthesis, genetics)
  • Glutathione (deficiency)
  • Homozygote
  • Hypothalamus (metabolism)
  • Insulin Resistance (genetics)
  • Intercellular Signaling Peptides and Proteins (biosynthesis, genetics)
  • Intracellular Signaling Peptides and Proteins (genetics)
  • Lipid Metabolism
  • Lipolysis (genetics)
  • Liver (metabolism)
  • Liver Glycogen (metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Mutant Strains (genetics, metabolism)
  • Motor Activity
  • NADP (deficiency)
  • Neuropeptide Y (biosynthesis, genetics)
  • Neuropeptides (biosynthesis, genetics)
  • Obesity (genetics)
  • Orexins
  • Oxygen (metabolism)
  • Oxygen Consumption (genetics)
  • Pentose Phosphate Pathway (genetics)
  • Proteins (genetics, physiology)
  • Retinal Degeneration (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: